KRAS and neoplasm: The oncogene Kras-G12D increases the expression of IL-33 in PDAC cells, and fungi in PDAC tissue can drive IL-33 secretion, further recruiting and activating Th2 cells and ILC2 in the tumor, ultimately inhibiting the antitumor immune response and promoting tumor progression (52).